Anticancer Drugs Course
Master first-line EGFR TKI strategies for mutant NSCLC, handle toxicities like rash and diarrhea, and manage resistance with biopsies and second-line options. This course equips oncologists with practical tools to boost patient outcomes and chat clearly bout treatment plans, drawing from solid evidence for confident decisions in everyday practice.

from 4 to 360h flexible workload
valid certificate in your country
What will I learn?
Get a practical rundown on first-line treatments for EGFR-mutated NSCLC, covering targeted therapies, chemo-immunotherapy, and chemo. Dive into how dem drugs work, dosages, side effects, ways to prevent and manage dem, resistance signs, next-line choices, monitoring, and straight-talk skills for solid, evidence-backed decisions.
Elevify advantages
Develop skills
- Pick first-line EGFR TKI regimens based on latest trial data.
- Plan imaging, re-biopsy, and liquid biopsy for resistance assessment.
- Match resistance to targeted therapy, chemo, or trials for next steps.
- Prevent and handle EGFR TKI rash, diarrhea, ILD, and low blood counts.
- Counsel patients clearly on goals, side effects, and progression plans.
Suggested summary
Before starting, you can change the chapters and the workload. Choose which chapter to start with. Add or remove chapters. Increase or decrease the course workload.What our students are saying
FAQs
Who is Elevify? How does it work?
Do the courses come with a certificate?
Are the courses free?
What is the course duration?
What are the courses like?
How do the courses work?
What is the course time?
What is the cost or price of the courses?
What is an EAD or online course and how does it work?
PDF Course